Delivery Order 36C26324D0042-36C26326N0200

Award Date 10/1/25
Potential Completion Date 3/31/26
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Pine Pharmaceuticals LLC, a limited liability company located in Tonawanda, New York, is for the provision of 503B compounding pharmaceuticals to the U.S. Department of Veterans Affairs Veterans Health Administration. The contract, valued at $48,136.00, is a delivery order with a firm fixed price and has an ultimate completion date of September 30, 2025. The contract is not designated as a set-aside and was awarded on October 1, 2024. Pine Pharmaceuticals is an...
This is a federal contract award to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract, valued at $37,117.80, is a delivery order from the U.S. Department of Veterans Affairs Veterans Health Administration (VA VHA) for 503B compounding pharmaceutical services. The contract has a period of performance ending on September 30, 2024. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in pharmaceutical...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company in Tonawanda, New York. The contract, valued at $119,062.95, is for the production of drug capsules. The award does not have a set-aside designation. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in pharmaceutical compounding,...
This $116,700.00 firm fixed price purchase order was awarded to Pine Pharmaceuticals LLC, a for-profit limited liability company, by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations. The contract has a completion date of August 17, 2023 and does not have a set-aside designation. Based on the information provided, Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that has previously provided pharmaceutical...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services. The $69,466.32 firm fixed-price delivery order was awarded to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of intravenous stable isotope glucose (6,6 deuterated glucose) to support metabolic research. The contract has a...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Department of Health and Human Services, awarded a $44,606.40 firm fixed-price purchase order to Pine Pharmaceuticals LLC, a small business contractor located in Tonawanda, New York. The contract is for the acquisition of intravenous stable isotopes, specifically D5 glycerol and 6,6 D2-glucose, to support metabolic research. This award is not associated with a larger contract vehicle. The contract has a...
This is a $27,384.76 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of 3 batches/shipments of 60 units each of the intravenous stable isotope D5 glycerol, which is required for metabolic research studies conducted...
This is a $98,362.68 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 to Pharmacy Buying Association, Inc. (PBA Health), a for-profit small business. The contract is for the delivery of various pharmaceutical products to VA medical facilities, including Consolidated Mail Outpatient Pharmacies (CMOPs), to replenish their stock. The original solicitation, posted on FedBizOpps, requested quotes for pharmaceutical products...
This $85,671.36 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 to Pharmacy Buying Association, Inc. (PBA Health), a for-profit small business. The award is for the delivery of pharmaceuticals, with an ultimate completion date of November 30, 2018. PBA Health is a prime contractor that specializes in providing pharmaceutical products and medical supplies to federal healthcare agencies, particularly the VA. The company...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Pharmacy Buying Association, Inc. (PBA Health), a for-profit small business organization. The contract is for the delivery of pharmaceutical products, including Angragrelide HCL, Chlorzoxazone, Estradiol 0.1 mg, and Estradiol 0.0375 mg, to VA healthcare facilities. The contract has a firm fixed-price value of $100,407.58 and an ultimate completion date of April 14, 2017. PBA Health has an existing Indefinite...
  • 36C26324D0042
    Indefinite Delivery Contract
  • 36C26324D0042-36C26326N0200
    Delivery Order

This federal contract award to Pine Pharmaceuticals LLC, a for-profit limited liability company in Tonawanda, New York, is for the provision of 503B compounding pharmaceutical products. The $20,379.00 firm fixed price delivery order contract was awarded on October 1, 2025 by the Veterans Integrated Service Network 23, a civilian agency, with a period of performance through March 31, 2026. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in pharmaceutical compounding, repackaging, and production of specialized pharmaceutical products, primarily serving scientific and medical research institutions. The company has an established track record of federal contract awards, particularly with agencies within the Department of Health and Human Services, for the procurement and manufacture of intravenous stable isotopes and other specialized pharmaceutical products. This award is not associated with a set-aside program.

Generated 10/2/25, 10:57 AM